deuterium has been researched along with Atherosclerotic Parkinsonism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JC; Moon, MH; Yang, JS | 1 |
| Bergh, JJ; Castagnoli, N; Ogunrombi, MO; Petzer, JP; Pretorius, A; Terre'blanche, G | 1 |
2 other study(ies) available for deuterium and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Simultaneous Relative Quantification of Various Polyglycerophospholipids with Isotope-Labeled Methylation by Nanoflow Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectrometry.
Topics: 1-Methyl-4-phenylpyridinium; Cell Line, Tumor; Chromatography, High Pressure Liquid; Deuterium; Humans; Isotope Labeling; Methylation; Oxidopamine; Parkinson Disease, Secondary; Phosphatidylglycerols; Rotenone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2019 |
Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Catalysis; Cattle; Deuterium; Dopamine Agents; Isotope Labeling; Kinetics; Liver; Monoamine Oxidase; Neurotoxins; Oxidation-Reduction; Papio; Parkinson Disease, Secondary; Pyrroles | 2008 |